TENX vs GEG Comparison

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. The Group conducts its operations through two business segments: Alternative Credit and Real Estate. Key revenue comes from the Real Estate segment, which includes a full-service, end-to-end real estate platform combining investment expertise and turnkey execution capabilities for the IOS sector. The Alternative Credit segment focuses on income generation and capital preservation by investing in debt and income-generating securities, direct lending, CLOs, and specialty finance businesses, including factoring, asset-based lending, and healthcare.